ArticleInvestigational new drugs2022

Efficacy and safety of amrubicin monotherapy after atezolizumab plus carboplatin and etoposide in patients with relapsed small-cell lung cancer.

Hisao Imai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.